APO RESEARCH · REPORT
10-Deacetylbaccatine III
A taxane intermediate supplied as 10-deacetylbaccatin III for separately specified synthesis or research uses.
Product & engineering
Understand the product.
Chemical identity, assay basis, impurities, solvent or carrier and the supplied form determine the material boundary. The substance name and an illustrative container do not establish grade, suitability, handling conditions or a finished-product performance claim.
What turns activity into demand
The selected edition segments 10-Deacetylbaccatine III by ≥95%; ≥98.0%; Others. Its application or channel categories include Production of Docetaxel; Production of Paclitaxel; Others.
The commercial boundary
Read those groups within the selected report’s geography, years and measure. Component, material and finished-system activity should not be combined unless that edition explicitly defines the same commercial scope.
Which composition and supplied-form specification defines the chemical product?
Chemical identity, assay basis, impurities, solvent or carrier and the supplied form determine the material boundary. The substance name and an illustrative container do not establish grade, suitability, handling conditions or a finished-product performance claim. The selected edition’s categories describe its research segmentation; a supplier specification and application-level acceptance test define the particular purchased product.
Technical reading
Selected research
Market Structure
Global 10-Deacetylbaccatine III Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global 10-Deacetylbaccatine III market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for 10-Deacetylbaccatine III is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for 10-Deacetylbaccatine III is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 10-Deacetylbaccatine III is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for 10-Deacetylbaccatine III is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 10-Deacetylbaccatine III include Indena, South Pharmaceutical, Sai Phytoceuticals, Sarv Biolabs Pvt, Aphios, Taxus Pharma, Yunnan Hande, Kavya Pharma and Jinhe, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines 10-Deacetylbaccatine III output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of 10-Deacetylbaccatine III by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global 10-Deacetylbaccatine III market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of 10-Deacetylbaccatine III and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents 10-Deacetylbaccatine III sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 10-Deacetylbaccatine III market size, projected growth trends, production technologies, key applications, and end-use industries.
10-Deacetylbaccatine III Segment by Company
Indena
South Pharmaceutical
Sai Phytoceuticals
Sarv Biolabs Pvt
Aphios
Taxus Pharma
Yunnan Hande
Kavya Pharma
Jinhe
Phyton Biotech
Deccan Nutraceuticals
Alchem International
10-Deacetylbaccatine III Segment by Type
≥95%
≥98.0%
Others
10-Deacetylbaccatine III Segment by Application
Production of Docetaxel
Production of Paclitaxel
Others
10-Deacetylbaccatine III Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10-Deacetylbaccatine III market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 10-Deacetylbaccatine III and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10-Deacetylbaccatine III.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the 10-Deacetylbaccatine III market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 10-Deacetylbaccatine III industry.
Chapter 3: Detailed analysis of 10-Deacetylbaccatine III market competition landscape. Including 10-Deacetylbaccatine III manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of 10-Deacetylbaccatine III by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of 10-Deacetylbaccatine III in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ≥95%
- ≥98.0%
- Others
Applications
- Production of Docetaxel
- Production of Paclitaxel
- Others
Companies covered
- Indena
- South Pharmaceutical
- Sai Phytoceuticals
- Sarv Biolabs Pvt
- Aphios
- Taxus Pharma
- Yunnan Hande
- Kavya Pharma
- Jinhe
- Phyton Biotech
- Deccan Nutraceuticals
- Alchem International
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global 10-Deacetylbaccatine III Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global 10-Deacetylbaccatine III Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global 10-Deacetylbaccatine III Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global 10-Deacetylbaccatine III Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global 10-Deacetylbaccatine III Market Dynamics
- 2.1 10-Deacetylbaccatine III Industry Trends
- 2.2 10-Deacetylbaccatine III Industry Drivers
- 2.3 10-Deacetylbaccatine III Industry Opportunities and Challenges
- 2.4 10-Deacetylbaccatine III Industry Restraints
3 10-Deacetylbaccatine III Market by Manufacturers
- 3.1 Global 10-Deacetylbaccatine III Production Value by Manufacturers (2021-2026)
- 3.2 Global 10-Deacetylbaccatine III Production by Manufacturers (2021-2026)
- 3.3 Global 10-Deacetylbaccatine III Average Price by Manufacturers (2021-2026)
- 3.4 Global 10-Deacetylbaccatine III Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 10-Deacetylbaccatine III Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global 10-Deacetylbaccatine III Manufacturers, Product Type & Application
- 3.7 Global 10-Deacetylbaccatine III Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 10-Deacetylbaccatine III Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 10-Deacetylbaccatine III Players Market Share by Production Value in 2025
- 3.8.3 2025 10-Deacetylbaccatine III Tier 1, Tier 2, and Tier 3
4 10-Deacetylbaccatine III Market by Type
- 4.1 10-Deacetylbaccatine III Type Introduction
- 4.1.1 ≥95%
- 4.1.2 ≥98.0%
- 4.1.3 Others
- 4.2 Global 10-Deacetylbaccatine III Production by Type
- 4.2.1 Global 10-Deacetylbaccatine III Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global 10-Deacetylbaccatine III Production by Type (2021-2032)
- 4.2.3 Global 10-Deacetylbaccatine III Production Market Share by Type (2021-2032)
- 4.3 Global 10-Deacetylbaccatine III Production Value by Type
- 4.3.1 Global 10-Deacetylbaccatine III Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global 10-Deacetylbaccatine III Production Value by Type (2021-2032)
- 4.3.3 Global 10-Deacetylbaccatine III Production Value Market Share by Type (2021-2032)
5 10-Deacetylbaccatine III Market by Application
- 5.1 10-Deacetylbaccatine III Application Introduction
- 5.1.1 Production of Docetaxel
- 5.1.2 Production of Paclitaxel
- 5.1.3 Others
- 5.2 Global 10-Deacetylbaccatine III Production by Application
- 5.2.1 Global 10-Deacetylbaccatine III Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global 10-Deacetylbaccatine III Production by Application (2021-2032)
- 5.2.3 Global 10-Deacetylbaccatine III Production Market Share by Application (2021-2032)
- 5.3 Global 10-Deacetylbaccatine III Production Value by Application
- 5.3.1 Global 10-Deacetylbaccatine III Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global 10-Deacetylbaccatine III Production Value by Application (2021-2032)
- 5.3.3 Global 10-Deacetylbaccatine III Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Indena
- 6.1.1 Indena Company Information
- 6.1.2 Indena Business Overview
- 6.1.3 Indena 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.1.4 Indena 10-Deacetylbaccatine III Product Portfolio
- 6.1.5 Indena Recent Developments
- 6.2 South Pharmaceutical
- 6.2.1 South Pharmaceutical Company Information
- 6.2.2 South Pharmaceutical Business Overview
- 6.2.3 South Pharmaceutical 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.2.4 South Pharmaceutical 10-Deacetylbaccatine III Product Portfolio
- 6.2.5 South Pharmaceutical Recent Developments
- 6.3 Sai Phytoceuticals
- 6.3.1 Sai Phytoceuticals Company Information
- 6.3.2 Sai Phytoceuticals Business Overview
- 6.3.3 Sai Phytoceuticals 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.3.4 Sai Phytoceuticals 10-Deacetylbaccatine III Product Portfolio
- 6.3.5 Sai Phytoceuticals Recent Developments
- 6.4 Sarv Biolabs Pvt
- 6.4.1 Sarv Biolabs Pvt Company Information
- 6.4.2 Sarv Biolabs Pvt Business Overview
- 6.4.3 Sarv Biolabs Pvt 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.4.4 Sarv Biolabs Pvt 10-Deacetylbaccatine III Product Portfolio
- 6.4.5 Sarv Biolabs Pvt Recent Developments
- 6.5 Aphios
- 6.5.1 Aphios Company Information
- 6.5.2 Aphios Business Overview
- 6.5.3 Aphios 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.5.4 Aphios 10-Deacetylbaccatine III Product Portfolio
- 6.5.5 Aphios Recent Developments
- 6.6 Taxus Pharma
- 6.6.1 Taxus Pharma Company Information
- 6.6.2 Taxus Pharma Business Overview
- 6.6.3 Taxus Pharma 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.6.4 Taxus Pharma 10-Deacetylbaccatine III Product Portfolio
- 6.6.5 Taxus Pharma Recent Developments
- 6.7 Yunnan Hande
- 6.7.1 Yunnan Hande Company Information
- 6.7.2 Yunnan Hande Business Overview
- 6.7.3 Yunnan Hande 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.7.4 Yunnan Hande 10-Deacetylbaccatine III Product Portfolio
- 6.7.5 Yunnan Hande Recent Developments
- 6.8 Kavya Pharma
- 6.8.1 Kavya Pharma Company Information
- 6.8.2 Kavya Pharma Business Overview
- 6.8.3 Kavya Pharma 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.8.4 Kavya Pharma 10-Deacetylbaccatine III Product Portfolio
- 6.8.5 Kavya Pharma Recent Developments
- 6.9 Jinhe
- 6.9.1 Jinhe Company Information
- 6.9.2 Jinhe Business Overview
- 6.9.3 Jinhe 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.9.4 Jinhe 10-Deacetylbaccatine III Product Portfolio
- 6.9.5 Jinhe Recent Developments
- 6.10 Phyton Biotech
- 6.10.1 Phyton Biotech Company Information
- 6.10.2 Phyton Biotech Business Overview
- 6.10.3 Phyton Biotech 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.10.4 Phyton Biotech 10-Deacetylbaccatine III Product Portfolio
- 6.10.5 Phyton Biotech Recent Developments
- 6.11 Deccan Nutraceuticals
- 6.11.1 Deccan Nutraceuticals Company Information
- 6.11.2 Deccan Nutraceuticals Business Overview
- 6.11.3 Deccan Nutraceuticals 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.11.4 Deccan Nutraceuticals 10-Deacetylbaccatine III Product Portfolio
- 6.11.5 Deccan Nutraceuticals Recent Developments
- 6.12 Alchem International
- 6.12.1 Alchem International Company Information
- 6.12.2 Alchem International Business Overview
- 6.12.3 Alchem International 10-Deacetylbaccatine III Production, Value and Gross Margin (2021-2026)
- 6.12.4 Alchem International 10-Deacetylbaccatine III Product Portfolio
- 6.12.5 Alchem International Recent Developments
7 Global 10-Deacetylbaccatine III Production by Region
- 7.1 Global 10-Deacetylbaccatine III Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global 10-Deacetylbaccatine III Production by Region (2021-2032)
- 7.2.1 Global 10-Deacetylbaccatine III Production by Region (2021-2026)
- 7.2.2 Global 10-Deacetylbaccatine III Production Forecast by Region (2027-2032)
- 7.3 Global 10-Deacetylbaccatine III Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global 10-Deacetylbaccatine III Production Value by Region (2021-2032)
- 7.4.1 Global 10-Deacetylbaccatine III Production Value by Region (2021-2026)
- 7.4.2 Global 10-Deacetylbaccatine III Production Value by Region (2027-2032)
- 7.5 Global 10-Deacetylbaccatine III Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America 10-Deacetylbaccatine III Production Value (2021-2032)
- 7.6.2 Europe 10-Deacetylbaccatine III Production Value (2021-2032)
- 7.6.3 Asia-Pacific 10-Deacetylbaccatine III Production Value (2021-2032)
- 7.6.4 South America 10-Deacetylbaccatine III Production Value (2021-2032)
- 7.6.5 Middle East & Africa 10-Deacetylbaccatine III Production Value (2021-2032)
8 Global 10-Deacetylbaccatine III Consumption by Region
- 8.1 Global 10-Deacetylbaccatine III Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global 10-Deacetylbaccatine III Consumption by Region (2021-2032)
- 8.2.1 Global 10-Deacetylbaccatine III Consumption by Region (2021-2026)
- 8.2.2 Global 10-Deacetylbaccatine III Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America 10-Deacetylbaccatine III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America 10-Deacetylbaccatine III Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe 10-Deacetylbaccatine III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe 10-Deacetylbaccatine III Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific 10-Deacetylbaccatine III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific 10-Deacetylbaccatine III Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America 10-Deacetylbaccatine III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America 10-Deacetylbaccatine III Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa 10-Deacetylbaccatine III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa 10-Deacetylbaccatine III Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 10-Deacetylbaccatine III Value Chain Analysis
- 9.1.1 10-Deacetylbaccatine III Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 10-Deacetylbaccatine III Production Mode & Process
- 9.2 10-Deacetylbaccatine III Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 10-Deacetylbaccatine III Distributors
- 9.2.3 10-Deacetylbaccatine III Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst